Viewing Study NCT06211335


Ignite Creation Date: 2025-12-24 @ 10:07 PM
Ignite Modification Date: 2026-01-01 @ 11:35 AM
Study NCT ID: NCT06211335
Status: RECRUITING
Last Update Posted: 2025-04-18
First Post: 2024-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
Sponsor: Shyam S.D. Rao
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Recurrent Head and Neck Squamous Cell Carcinoma View
None Metastatic Head and Neck Squamous Cell Carcinoma View
None Refractory Head and Neck Squamous Cell Carcinoma View
Keywords: